Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    "Nephrosclerosis"
Show Display Options
RSS Create an RSS feed from your search for:
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed TRK-100STP Clinical Study - Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis)
Conditions: Chronic Renal Failure;   Glomerular Disease;   Nephrosclerosis
Interventions: Drug: TRK-100STP high dose;   Drug: TRK-100STP low dose;   Drug: Placebo
2 Terminated
Has Results
Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease
Conditions: Proteinuric Kidney Disease;   Diabetic Nephropathy;   Hypertensive Nephrosclerosis;   IgA Nephropathy;   Focal Segmental Glomerulosclerosis;   Glomerulopathy (Obesity-associated);   Glomerulonephritis, Membranous
Interventions: Drug: Aliskiren;   Drug: Valsartan
3 Completed TRK-100STP PhaseII Clinical Study -Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis)
Condition: Renal Insufficiency, Chronic
Interventions: Drug: Beraprost;   Drug: Placebo

Indicates status has not been verified in more than two years